GnRH-mediated suppression of S100A4 expression inhibits endometrial epithelial cell proliferation in sheep via GNAI2/MAPK signaling

X Jiao, Z Chu, M Li, J Wang, Z Ren, L Wang… - Frontiers in Veterinary …, 2024 - frontiersin.org
Background Gonadotrophin-releasing hormone (GnRH) administration significantly
decreases the pregnancy rate of recipient ewes after embryo transfer, possibly because …

[HTML][HTML] 中医药治疗子宫腺肌病伴不孕症的研究概况

李芳源, 马嘉敏, 朱璨, 夏宛廷, 张慧敏… - Traditional Chinese …, 2023 - hanspub.org
子宫腺肌病是临床常见疾病, 常伴发不孕症. 改善子宫腺肌病患者的生育力逐渐成为亟需解决的
问题. 子宫腺肌病伴不孕症的核心病机是瘀阻冲任, 病性多虚实夹杂, 笔者从气血阴阳角度归纳 …

[HTML][HTML] Fertility and Obstetric Outcomes of Assisted Reproductive Technology (ART) in Women With Adenomyosis Following Gonadotropin-Releasing Hormone …

AR Rao, UP Duraikannan, DR Rao, P Giridhar… - Cureus, 2023 - ncbi.nlm.nih.gov
Introduction: Adenomyosis is an ambiguous disorder causing a wide variety of implications
from dysmenorrhea, heavy menstrual bleeding, and infertility to pregnancy complications …

Αδενομύωση και υπογονιμότητα

Ο Ζαφειράτης - repo.lib.duth.gr
Adenomyosis is a pathological disorder of the uterus in which the endometrial glands and
stroma are found abnormally in the myometrium of the uterus. The disease is increasingly …

[PDF][PDF] What is new in Adenomyosis and Assisted Reproductive Technologies? Best Articles from the Past Year O que há de novo em Adenomiose e Procriação …

R Sousa-Santos, LF Vicente - Acta Obstet Ginecol Port, 2023 - fspog.org
A adenomiose é uma doença prevalente, difícil de classificar, frequentemente presente nas
mulheres com infertilidade e submetidas a tratamentos de Procriação Medicamente …

O que há de novo em Adenomiose e Procriação Medicamente Assistida? Os melhores artigos do último ano

R Sousa-Santos, LF Vicente - 2023 - sidalc.net
A adenomiose é uma doença prevalente, difícil de classificar, frequentemente presente nas
mulheres com infertilidade e submetidas a tratamentos de Procriação Medicamente …